Half-Life
Notice
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
What is Half-Life?
In the context of peptide research, half-life refers to the time required for the concentration or biological activity of a peptide to decrease by 50% within a given system. This can refer to the peptide's stability in solution (chemical half-life), its persistence in a biological system such as plasma or serum (biological half-life), or the duration of its biological effect (pharmacodynamic half-life). Half-life is a fundamental pharmacokinetic parameter that helps researchers understand how long a peptide remains active and at what dosing intervals it should be studied.
Factors That Influence Peptide Half-Life
Natural peptides in biological systems typically have short half-lives, often ranging from just a few minutes to several hours. This is primarily due to rapid enzymatic degradation by proteases and peptidases present in plasma, tissues, and the gastrointestinal tract, as well as renal clearance. Several factors determine a specific peptide's half-life:
- Sequence Composition: Certain amino acid sequences are more resistant to proteolytic cleavage than others.
- Molecular Size: Smaller peptides are generally cleared more rapidly by the kidneys.
- Structural Modifications: Cyclization, PEGylation, lipidation, or D-amino acid substitution can extend half-life by improving protease resistance.
- Binding Interactions: Peptides that bind to serum proteins (such as albumin) may exhibit prolonged circulation times.
In Vitro vs. In Vivo Half-Life
It is important to distinguish between in vitro and in vivo half-life measurements. In vitro half-life, measured in a controlled laboratory environment (such as stability in buffer or plasma at 37C), provides baseline data on a peptide's chemical and enzymatic stability. In vivo half-life, measured in a living system, reflects the combined effects of absorption, distribution, metabolism, and excretion (ADME). Researchers often begin with in vitro stability studies to guide the design of subsequent in vivo pharmacokinetic experiments.